Cedarburg Hauser expands API capacity at Wisconsin site

Cedarburg Hauser expands API capacity at Wisconsin site

12:01 PM, 27th September 2012
Cedarburg Hauser expands API capacity at Wisconsin site
R Anthony Laughrey, Chief Executive Officer, Cedarburg Hauser.

GRAFTON, US: Cedarburg Hauser Pharmaceuticals (CHP) has expanded the capacity of its Wisconsin based active pharmaceutical ingredient (API) manufacturing plant. The expansion efforts are a result of an increased demand for contract manufacturing of commercial APIs and are accompanied by additional upgrades aimed at improving safety and GMP systems.

“These improvements increase our total reactor capacity by nearly 50 per cent. We have also added a reactor and chiller that allow for cryogenic reactions in our GMP labs,” said John Flahive, newly hired Director of Operations, Cedarburg Hauser.

In addition to the new reactors, Cedarburg Hauser has also made improvements to the air handling systems in the GMP manufacturing suites, installed a reverse osmosis water system, improved isolation capabilities and upgraded their Emerson DeltaV Digital Automation System.

“The flexibility afforded by the additional reactor capacity allows us to better meet our customer’s on-time and on-budget requirements. We will continue to invest in our business as we strive to be the premier contract API manufacturer,” commented R Anthony Laughrey, Chief Executive Officer, Cedarburg Hauser.

© WOC News

 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Evonik to build first MMA production plant using AVENEER process

ESSEN, GERMANY: Evonik Industries is starting basic planning for a new methyl methacrylate (MMA) production plant using the AVENEER process at its Mob ...

Read more
Solvay opens two rare earth recycling units in France

BRUSSELS, BELGIUM: Solvay has opened two rare earth recycling units in France. In order to diversify its sources of supply and preserve resources, the ...

Read more
Scientists develop biotechnology to purify fracking wastewater

MINNEAPOLIS, US: Fracking, the use of hydraulic pressure to release natural gas and oil from shale, has the potential to meet energy demands with US r ...

Read more
Lonza to develop, manufacture Intellect’s antibody drug conjugate

NEW YORK, US/BASEL, SWITZERLAND: Lonza announced that Intellect Neurosciences awarded the future development and manufacture of the antibody drug conj ...

Read more
Gevo switches to ethanol production, optimizes isobutanol technology

ENGLEWOOD, US: Gevo is switching its Luverne, MN biorefinery back to ethanol production while it works to optimize isobutanol production rates. The co ...

Read more
Incitec Pivot defers developing ammonium nitrate unit at Newcastle site

VICTORIA, AUSTRALIA: Incitec Pivot Limited (IPL) has suspended its feasibility study on the development of an ammonium nitrate manufacturing complex a ...

Read more